USFDA completes inspection at Dr. Reddy's formulations manufacturing facility in Srikakulam

13 May 2023 Evaluate

United States Food & Drug Administration (USFDA) has completed a product-specific Pre-Approval Inspection (PAI) and a routine GMP inspection at Dr. Reddy's Laboratories’ formulations manufacturing facility in Srikakulam (FTO SEZ PU2). The inspection was conducted from May 8, 2023 to May 12, 2023. The company has been issued a Form 483 with four observations, which it will address within the stipulated timeline. 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1271.05 5.10 (0.40%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×